Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Lilly weight loss drug prevents diabetes, company says - AOL

   www.aol.com/news/lilly-weight-loss-drug-prevents...

   A new class of medications, called GLP-1s, including tirzepatide, which Lilly sells as Zepbound for weight loss, is the first effective treatment for many people.

3. Tirzepatide - Wikipedia

   en.wikipedia.org/wiki/Tirzepatide

   Tirzepatide is an analogue of gastric inhibitory polypeptide (GIP), a human hormone that stimulates the release of insulin from the pancreas. Tirzepatide is a linear polypeptide of 39 amino acids that has been chemically modified by lipidation to improve its uptake into cells and its stability to metabolism. [ 30]

4. Eli Lilly's weight-loss drug cuts diabetes risk by 94% in trial

   www.aol.com/news/eli-lillys-weight-loss-drug...

   Treatment with tirzepatide, the chemical name for Lilly's obesity drug Zepbound and diabetes treatment Mounjaro, resulted in an average weight reduction of 22.9%, compared to just 2.1% for the ...

5. New Weight Loss Drug Zepbound Cost Break Down: With and ... - AOL

   www.aol.com/weight-loss-drug-zepbound-cost...

   Zepbound, which is the brand name for tirzepatide, targets glucagon-like peptide 1 agonists which stimulate the body to produce more insulin when blood sugars start to rise, along with something ...

6. Mounjaro for Weight Loss: What You Need to Know Before ... - AOL

   www.aol.com/mounjaro-weight-loss-know-starting...

   When it comes to weight loss, Mounjaro can help those with and without type 2 diabetes lose weight. Doses of 5 milligrams (mg) to 15mg of tirzepatide can help those with type 2 diabetes lose up to ...

7. Cagrilintide/semaglutide - Wikipedia

   en.wikipedia.org/wiki/Cagrilintide/semaglutide

   [1] [2] In a Phase II trial, weight loss averaged -15.6 percent after 32 weeks, making CagriSema comparable in efficacy to tirzepatide. [3] [4] A future trial sponsored by Novo Nordisk is comparing tirzepatide and CagriSema head-to-head. [5] As of 2023, CagriSema is in a Phase III trial. [6]

8. Eli Lilly's tirzepatide cuts heart failure risks, company says

   www.aol.com/news/eli-lillys-tirzepatide-cuts...

   August 1, 2024 at 6:45 AM. AJ Mast. Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with ...

9. FDA warns online vendors selling misbranded weight-loss ... - AOL

   www.aol.com/news/fda-warns-online-vendors...

   Semaglutide is an active ingredient in Novo Nordisk's Wegovy and Ozempic, while Eli Lilly's diabetes drug sold as Mounjaro and its recently approved weight-loss drug Zepbound use tirzepatide.